Leuk Res. 2009 Sep;33(9):1212-6. Epub 2009 Feb 20. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic...
Terrific interview, Betsy! Thank you. When Children get Cancer: Help for Mom and Dad Direct link to interview: http://bit.ly/9FrWU [Non-text portions of this...
CLIMB (Children's Lives Include Moments of Bravery) The need for emotional support for children whose parents have cancer is greater than ever before. Link to...
Obstacles to Enrolling Our Patients in Trials http://www.lymphomation.org/docsurvey-chart.PDF Any surprises here? All the best, ~ Karl Patients Against...
This chart shows obstacles that were cited as *most signficant* by oncologists ... Most signficant: http://www.lymphomation.org/docsurvey-chart2.PDF Our...
Journal of Clinical Oncology, Vol 27, No 31 (November 1), 2009: pp. 5208-5212 5-Year Survival in Patients With Relapsed or Refractory Chronic Lymphocytic...
Tips from Dr. Himle Link to interview: http://www.lymphomation.org/anxietydrugs.htm#tips My notes: * Make a list of blessing in your life on an index card - ...
Hello. I am a PhD student at Walden University. My research project is studying factors that affect how people understand consent forms for research. This...
Well, I see that the link I though was in my post did not work. I am copying the real link for you to use here. Please copy it into your browser and it will...
FDA Approves New Treatment for Chronic Lymphocytic Leukemia The U.S. Food and Drug Administration today approved Arzerra (ofatumumab) for patients with chronic...
Summary taken from notes (could have errors) CLINICAL UTILITY OF PET: * Reproducibility (No) * Improves care (Sometimes) * Improves outcomes (Not known...
Pbox-15 kills cancer cells without harming healthy cells Pbox-15, a potential new drug compound discovered by Irish clinical scientists, is found to be highly...
A Genomic Approach to Improve Prognosis and Predict Therapeutic Response in Chronic Lymphocytic Leukemia. Daphne R Friedman, J Brice Weinberg, William T Barry,...
Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study...
Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis. VA Morrison Clin...
A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia. ...
Azacytidine is a so-called epigenetic agent, which might "activate tumor suppressor genes silenced by hypermethylation, resulting in an antitumor effect." The...
Rare Disease Treated Using Gene Therapy http://www.npr.org/templates/story/story.php?storyId=120118988 Not related to lymphoma directly, but if safety is...
Published online October 19, 2009 The Journal of Immunology, 2009, 183, 6145 -6150 doi:10.4049/jimmunol.0901596 The Proteasome Inhibitor Bortezomib Enhances...
Greetings, The shortest distance between two points ... or the clinical use of improved agents against lymphoma is the efficient enrollment in clinical trials...
This enlightening article by Ralph Moss is especially relevant to blood cancers. (andy) Personalized Oncology? Sunday, 08 November 2009 The latest buzzword in...
Originally published as JCO Early Release 10.1200/JCO.2008.21.1169 on October 5 2009 Journal of Clinical Oncology, Vol 27, No 32 (November 10), 2009: pp....
Originally published as JCO Early Release 10.1200/JCO.2009.22.1291 on October 13 2009 Journal of Clinical Oncology, Vol 27, No 32 (November 10), 2009: pp....
Good morning, This for-profit group helps patients to participate in lymphoma trials as described. http://www.pharmatechoncology.com:80/patients/lymphoma ...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
